Healthcare | June 09, 2026
Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
We are building the bridge between complex molecular data and everyday clinical decisions
The facility sets a new benchmark in respiratory diagnostics
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments
Fertility platform launches flagship clinic with advanced IVF tech
The accepted studies span several critical areas of oncology, including nutrition, genomics, precision medicine, patient-reported outcomes, and community-based cancer care
Vijay brings more than 28 years of experience across healthcare, technology, edtech, manufacturing, and global business environments
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
